Bivalent Ligands for the Treatment of Neurological Disorders
作者： Dana E. Selley , Yan Zhang , Kurt F. Hauser
DOI:
关键词:
摘要: Bivalent ligands that contain two pharmacophores linked through a spacer, one of which interacts with the μ-opioid receptor (MOR) and other co-receptor CC chemokine 5 (CCR5), are used for treatment neurological disorders such as those associated AIDS.
lens.org 参考文章(6)
S SUZUKI, L CHUANG, P YAU, R DOI, R CHUANG, Interactions of Opioid and Chemokine Receptors: Oligomerization of , and with CCR5 on Immune Cells Experimental Cell Research. ,vol. 280, pp. 192- 200 ,(2002) , 10.1006/EXCR.2002.5638
Guo Li, Lindsey C. Aschenbach, Jianyang Chen, Michael P. Cassidy, David L. Stevens, Bichoy H. Gabra, Dana E. Selley, William L. Dewey, Richard B. Westkaemper, Yan Zhang, Design, Synthesis, and Biological Evaluation of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives as μ Opioid Receptor Selective Antagonists Journal of Medicinal Chemistry. ,vol. 52, pp. 1416- 1427 ,(2009) , 10.1021/JM801272C
Yvonne Rook, Kai-Uwe Schmidtke, Friedemann Gaube, Dirk Schepmann, Bernhard Wünsch, Jörg Heilmann, Jochen Lehmann, Thomas Winckler, Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents Journal of Medicinal Chemistry. ,vol. 53, pp. 3611- 3617 ,(2010) , 10.1021/JM1000024
Chongguang Chen, Jin Li, George Bot, Imre Szabo, Thomas J. Rogers, Lee-Yuan Liu-Chen, Heterodimerization and cross-desensitization between the μ-opioid receptor and the chemokine CCR5 receptor European Journal of Pharmacology. ,vol. 483, pp. 175- 186 ,(2004) , 10.1016/J.EJPHAR.2003.10.033
Shijun Zhang, Ajay Yekkirala, Ye Tang, Philip S. Portoghese, A bivalent ligand (KMN-21) antagonist for μ/κ heterodimeric opioid receptors Bioorganic & Medicinal Chemistry Letters. ,vol. 19, pp. 6978- 6980 ,(2009) , 10.1016/J.BMCL.2009.10.045
Yunyun Yuan, Christopher K. Arnatt, Guo Li, Kendra M. Haney, Derong Ding, Joanna C. Jacob, Dana E. Selley, Yan Zhang, Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5 Organic and Biomolecular Chemistry. ,vol. 10, pp. 2633- 2646 ,(2012) , 10.1039/C2OB06801J